These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25852500)

  • 21. A unified biosocial theory of personality and its role in the development of anxiety states.
    Cloninger CR
    Psychiatr Dev; 1986; 4(3):167-226. PubMed ID: 3809156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
    Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
    Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
    Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NEUROBIOLOGICAL BASES OF ALCOHOL ADDICTION.
    Matošić A; Marušić S; Vidrih B; Kovak-Mufić A; Cicin-Šain L
    Acta Clin Croat; 2016 Mar; 55(1):134-50. PubMed ID: 27333729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
    Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
    Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperament traits and executive functions in Parkinson's disease.
    Luca A; Nicoletti A; Mostile G; Sciacca G; Dibilio V; Cicero CE; Raciti L; Donzuso G; Zappia M
    Neurosci Lett; 2018 Sep; 684():25-28. PubMed ID: 29940327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enrichment Effects on Adult Cognitive Development: Can the Functional Capacity of Older Adults Be Preserved and Enhanced?
    Hertzog C; Kramer AF; Wilson RS; Lindenberger U
    Psychol Sci Public Interest; 2008 Oct; 9(1):1-65. PubMed ID: 26162004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli.
    Dulawa SC; Grandy DK; Low MJ; Paulus MP; Geyer MA
    J Neurosci; 1999 Nov; 19(21):9550-6. PubMed ID: 10531457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?
    Loued-Khenissi L; Preuschoff K
    Curr Opin Neurol; 2015 Aug; 28(4):344-50. PubMed ID: 26110801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New evidence for a pain personality? A critical review of the last 120 years of pain and personality.
    Naylor B; Boag S; Gustin SM
    Scand J Pain; 2017 Oct; 17():58-67. PubMed ID: 28850375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salience and Default Mode Network Coupling Predicts Cognition in Aging and Parkinson's Disease.
    Putcha D; Ross RS; Cronin-Golomb A; Janes AC; Stern CE
    J Int Neuropsychol Soc; 2016 Feb; 22(2):205-15. PubMed ID: 26888617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
    Ardouin C; Chéreau I; Llorca PM; Lhommée E; Durif F; Pollak P; Krack P;
    Rev Neurol (Paris); 2009 Nov; 165(11):845-56. PubMed ID: 19683776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding Personality and Predicting Outcomes: The Utility of Cognitive-Behavioral Probes of Approach and Avoidance Motivation.
    Robinson MD; Boyd RL; Liu T
    Emot Rev; 2013 Jul; 5(3):. PubMed ID: 24223624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine restores cognitive motivation in Parkinson's disease.
    McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
    Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alexithymia in Parkinson's disease: a point of view on current evidence.
    Costa A; Caltagirone C
    Neurodegener Dis Manag; 2016 Jun; 6(3):215-22. PubMed ID: 27230483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pragmatic Language Disorder in Parkinson's Disease and the Potential Effect of Cognitive Reserve.
    Montemurro S; Mondini S; Signorini M; Marchetto A; Bambini V; Arcara G
    Front Psychol; 2019; 10():1220. PubMed ID: 31275189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term cognitive effects of deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease.
    Philipson J; Blomstedt P; Fredricks A; Hariz M; Stenmark Persson R; Jahanshahi M
    J Neurosurg; 2021 Feb; 134(2):357-365. PubMed ID: 32032954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-cultural traits for personality of patients with Parkinson's disease in Japan.
    Fujii C; Harada S; Ohkoshi N; Hayashi A; Yoshizawa K
    Am J Med Genet; 2000 Feb; 96(1):1-3. PubMed ID: 10686542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.
    Leplow B; Sepke M; Schönfeld R; Pohl J; Oelsner H; Latzko L; Ebersbach G
    J Neural Transm (Vienna); 2017 Feb; 124(2):217-225. PubMed ID: 27848033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.